eVTOL stayed in proof mode on June 14: JOBY closed at $9.15 on 23,620,500 shares, ACHR closed at $5.08 on 29,863,800 shares, and EH closed at $6.63 on 1,067,300 shares. With the U.S. 10-year yield at 4.49% and Fed Funds at 3.63%, capital is still expensive for companies that need time, certification, and cleaner operating data before the market will pay up. My view is that today’s tape tied all three names together around one question: which story is merely waiting for proof, and which story is still asking investors to fund uncertainty?
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Is Joby’s no-news trading a warning that the premium is fading, or just a pre-catalyst cleanup?
My read is that Joby’s move still looks more like a pre-catalyst cleanup than a full collapse in confidence. The raw data is unusually clean on that point. There was no fresh in-window IR, SEC, or FAA development for Joby, and the only incremental public-facing item was a FLYING Magazine piece on the Dayton Air Show simulator. That helps keep the eVTOL story visible, but it is not a valuation-driving event by itself. Even so, JOBY still traded 23.62 million shares and fell only 2.24% to $9.15. In a vacuum that is not good price action, but relative to the peer tape it matters: ACHR lost 4.15% and EH lost 2.79%, so Joby did not act like a uniquely broken stock.
The technicals support a cautious rather than catastrophic interpretation. JOBY’s RSI14 at 35.37 is weak, but it is still above ACHR’s 29.49 and EH’s 28.57. The stock also remains below SMA5 at 9.27 and well below SMA20 at 10.58, so I do not think investors should call this healthy momentum. The way I see it, the market is still willing to trade the name actively, but it is refusing to expand the multiple without a harder proof point. That is different from saying the narrative has failed. A failed narrative usually shows up as apathy, sharp relative underperformance, or visible institutional exits. None of those were confirmed in the files used for this run.
The institutional read is also more nuanced than the headline selloff suggests. ARKX still held JOBY at 2.53% as of June 11, although that was down 0.10 percentage points from the prior report. That is a trim, not a rejection. In a higher-rate backdrop, I think that distinction matters. When the 10-year sits at 4.49%, long-duration growth equities lose the benefit of easy patience, so capital tends to demand a timeline. Joby did not provide one in this window, which makes a positioning reset reasonable. But the absence of a new catalyst is not the same thing as the presence of a new problem.
So my directional lean here is cautiously constructive on the relative setup, even if the absolute trend is still weak. Joby looks like a stock being compressed by time rather than repriced for a broken thesis. That view would turn more skeptical if official silence continues and the stock starts lagging peers on similar no-news sessions. For now, I think investors are cleaning up exposure ahead of the next meaningful FAA or IR event, not abandoning the name outright. The stock still needs proof, but the tape says the market is waiting for that proof rather than walking away from the story.
Does Archer’s Stage 4 status make a 2028 launch realistic, or is the market still ahead of the certification clock?
I think the market is still ahead of the certification clock, and today’s price action looks like a partial correction toward reality. The key evidence is not promotional; it is procedural. The Archer daily file and the Every CRS Report explainer on AAM certification point to the same bottleneck: no AAM aircraft has yet received FAA certification, and the path still runs through type certification, production certification, and airworthiness certification before real scaled operations can begin. Innovate28 matters because it sets a sector goal for early operations in 2028, but it does not convert that goal into a company-level schedule that investors can underwrite as if it were already earned.
That is why Archer’s latest confirmed status matters so much. The file still places ACHR at Stage 4, with no fresh in-window FAA update. Put simply, the story has not moved through the remaining gates yet. Meanwhile the stock closed at $5.08, down 4.15%, on nearly 29.86 million shares, with RSI14 at 29.49. That combination tells me the market still cares intensely, but it is starting to discount how much future success should be prepaid today. ACHR remains below SMA5 at 5.30 and SMA20 at 6.07, so the tape is acting like a long-duration asset whose promised timing is being questioned.
The secondary coverage reinforces that interpretation rather than contradicting it. The foreignpolicyjournal.com buyout-target piece framed Archer as strategically valuable because of partner relationships that include Stellantis, Anduril, Korean Air, Japan Airlines, and Saudi PIF, but it also highlighted cash burn and unfinished FAA progress as the core risk. The Motley Fool’s 10x-outcome discussion made a similar point from a different angle: the upside case depends on certification and commercialization, not just narrative momentum. I agree with that framing. Strategic value can coexist with schedule risk; one does not erase the other.
My directional lean is cautious to skeptical on the market’s timing assumptions, not on Archer’s relevance as a company. A 2028 operating target remains possible, because the regulatory system is explicitly oriented toward that date. But from the evidence available in this run, it is not yet a comfortable base-case assumption. Until the sources show visible movement through the remaining certification layers, I think investors should treat 2028 as an aspiration that still needs multiple proofs, not as a de-risked timetable already supported by the file. The market seems to be learning that distinction the hard way.
What would EHang need to show next quarter to justify staying at 3.53x book despite a -49.17% ROE?
EHang needs more than a cosmetic improvement; it needs a materially better loss profile plus operating evidence that connects the certification story to financial conversion. The raw numbers are demanding. The EHang file cites GuruFocus showing annualized ROE at -49.17%, annualized net income at -€503.8 million, and average equity at €1,024.7 million. Separate GuruFocus pages also indicate no regular dividend, no useful operating-data disclosure in this fetch, and a visible P/B ratio of 3.53. My view is straightforward: a stock can trade richly against book while losses remain heavy, but only if investors can see a believable path from current burn to future operating leverage. That bridge is still thin here.
The arithmetic makes the problem hard to ignore. If average equity stays around €1,024.7 million, every 10 percentage points of ROE improvement is worth roughly €102.5 million of annualized earnings swing. That means a small tweak in the next quarter will not be enough to change the narrative. Even getting back to the prior 2025-12 annualized ROE of -27.26%, which the file says was materially better than the current reading, would imply a net-loss run rate roughly €224 million better than today’s -€503.8 million figure. That would still not make the company healthy. It would only move the discussion from sharply deteriorating to improving from a weak base.
The market tape lines up with that skepticism. EH closed at $6.63, below SMA5 at 7.13 and far below SMA20 at 8.94, while RSI14 at 28.57 says the stock is oversold. I think oversold matters tactically, but not enough to answer the valuation question. Without operating data, investors are left with balance-sheet and profitability clues rather than evidence of scaling demand, unit economics, or execution throughput. In a rate environment where the 10-year is still 4.49%, that missing bridge becomes more expensive. Time is not free for loss-making eVTOL names, and EHang is being asked to prove that the current loss structure is temporary rather than structural.
So my directional lean is skeptical until the next quarter shows three things at once: first, a clear narrowing in annualized losses from the current -€503.8 million zone; second, an ROE trend that reverses the deterioration from -27.26% to -49.17%; and third, more operating disclosure that helps investors see how financial repair is supposed to happen. I think that is the minimum credible package required to defend 3.53x book. Without it, the multiple still looks like investors are paying for future progress that has not yet shown up in the current numbers.
What to Watch Tomorrow
First, watch whether JOBY can hold up better than ACHR and EH again on another no-catalyst session, because relative resilience would support the view that this is still a positioning reset rather than a broken story.
Second, watch for any Archer certification-language change beyond Stage 4, because even a small procedural update would matter more than broad valuation debate for a 2028 timeline.
Third, watch for any new EHang operating or profitability disclosure, because the stock’s 3.53x book multiple needs a visible loss-improvement bridge to stay credible.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: eVTOL Daily Insight – 2026-06-13